Enlarge / Stephen Hahn, Commissioner of Food and Drugs at the US Food and Drug Administration (FDA), speaks during a Senate Health, Education, Labor and Pensions Committee hearing on June 30, 2020, in Washington, DC. (credit: Getty | Al Drago) Any experimental COVID-19 vaccines aspiring to earn regulatory approval from the Food and Drug Administration will need to prevent or decrease the severity of disease in at least 50 percent of people, the agency announced Tuesday. The criterium is part of a larger set of guidelines released by the agency for developing a vaccine to halt the spread of pandemic coronavirus, SARS-CoV-2—which causes COVID-19 and is now accelerating in much of the country after months of sustained devastation. With the guidelines, the FDA tried to dispel fears that the rush to develop a COVID-19 vaccine may come at the expense of adequate safety testing.
Similar Stories to Covid-19 Vaccine Must Protect 50% Of People For Approval, Fda Says on Bing News
Beth Mole, Ars Technica
Wed, 07/01/2020 - 3:25pm
Topics: enlarge drugs us food drug administration fda senate health education labor pensions committee june washington dc getty al drago sars-cov-2—which covid-19 fda commissioner stephen hahn read comments stephen hahn commissioner food drug administration fda covid-19 people approval agency prevent develop guidelines regulatory
BING NEWS:
- ‘Incorrect, Misleading’: ICMR Seeks Retraction Of BHU Study On Covaxin Side Effects, Warns Of Legal Action
ICMR said that it has noticed that the BHU's authors have acknowledged ICMR in similar previous papers without permission. It has asked for an explanation on why ICMR should not seek legal and ...
05/20/2024 - 6:34 am | View Link - COVID-19 vaccines: Get the facts
In some people, COVID-19 vaccines can lead to heart complications called myocarditis and pericarditis. Myocarditis is the swelling, also called inflammation, of the heart muscle. Pericarditis is the ...
05/20/2024 - 1:45 am | View Link - Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine
Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) today announce Nature Communications has published results from an integrated phase 1/2/3a/3b study ...
05/20/2024 - 1:30 am | View Link - As states loosen childhood vaccine requirements, health experts’ worries grow
Some lawmakers across the country are working to sidestep vaccine mandates, not just for COVID-19, but also for measles, polio and meningitis ...
05/19/2024 - 11:32 pm | View Link - Fact checking claims about vaccines as new COVID-19 variant emerges
About 3.5 years since the vaccines came to Kentucky — vaccine misinformation persists, even in Frankfort among elected officials.
05/14/2024 - 10:51 pm | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more